Strength

10; 10 mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884018601

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208518

On Market Since

12/19/2019

Pharmacological Classes

Analogs/Derivatives [Chemical/Ingredient]
Antihistamine
Histamine Receptor Antagonists
Vitamin B 6 [Chemical/Ingredient]
Vitamin B6 Analog

Price History

1W

0.0%

1M

+6.9%

3M

+0.7%

6M

-1.7%

1Y

+6.9%

3Y

-38.2%

5Y

-67.4%

All

-72.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.